Anti-hyperlipedemic activity of Panchavalkala Ghana Vati

Pharmacognostic and Experimnental Evaluation of Panchavalkala for Lekhana Karma W.s.r to Anti-Hyperlipedimic Activity - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/10/058952

Enrollment

Registered

2023-10-20

Start date

Unknown

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E785- Hyperlipidemia, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients who are confirmed to have increased levels of Cholesterol, Triglycerides and LDL with the help of a Lipid Profile Test.

Exclusion criteria

Exclusion criteria: 1. Patients who are K/C/O DM and HTN not under control 2. Immunocompromised patients 3. Patients with severe systemic illness.

Design outcomes

Primary

Measure	Time frame
To look for decrease in the levels of Cholesterol, Triglycerides and LDL through Lipid Profile TestTimepoint: Before Treatment and After Treatment (After 1 month)	—

Secondary

Measure	Time frame
Lab Values of Lipid Profile TestTimepoint: After 1 month	—

Countries

India

Contacts

Public ContactDrVeena M S

Rajiv Gandhi University of Health Sciences

raghunathgv2010@gmail.com9741744377

Outcome results